(Total Views: 497)
Posted On: 07/17/2020 1:32:50 PM
Post# of 145900
It is interesting, GSK bought the molecule, started trials against ARDS, then Aperion bought it back for about 300 million. There are a lot of big money from government and big pharma. And they have partnered with Sanofi.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)